Showing 61-65 of 143 news & articles:
Dermatology Data Can Direct Policy Priorities, but Gaps Reflect Inequities of Care

American Journal of Managed Care Mar 17, 2023 Christina Mattina Read the Full Article >> Speakers at the American Academy of Dermatology 2023 Annual Meeting highlighted the potential of DataDerm to tell the story of dermatological care in the United States, but some also cautioned that the registry only reflects those who have access to[…]

RAPID3 Scores May Help Determine the Impact of DMARD Therapy on PsA Severity

Dermatology Times Mar 19, 2023 Kaitlyn Bader Read the Full Article >>   A poster presentation from AAD 2023 explored RAPID3 scores to evaluate patient-reported outcomes in routine clinical practice therapy decisions regarding PsA. There is a lack of evidence investigating the impact of patient-reported outcomes (PROs) monitoring in routine clinical practice, according to a[…]

Interview with OM1’s Jessica Paulus at SCOPE

Published on: March 9, 2023 Applied Clinical Trials Watch the Full Interview >> Key Learning Objectives: Challenges people encounter when working with RWD How can RWD help address gaps in care? How OM1 engages or supports health equity research using RWD

Hard to Define, Harder to Find Patients: Using AI & Real-World Data to Understand Treatment Resistant Depression

Read the latest blog featuring Drs. Carl Marci & Joseph Zabinski in tHEORetically Speaking Written by: Undine McEvoy March 13, 2023 Mental health conditions can take a staggering toll on an individual physically, socially and financially. Many patients languish with partially effective or ineffective treatments, even though new options are constantly entering the market. At[…]

OM1 EXPANDS MENTAL HEALTH OFFERING WITH REAL-WORLD DATASETS INCLUDING SCHIZOPHRENIA AND BIPOLAR DISORDER

  Utilizing unique AI modeling capabilities with the new datasets, the company commits to improving personalized treatment options and outcomes for patients   BOSTON, March 2, 2023 — OM1 a leading real-world data, outcomes and technology company with a focus on chronic conditions, today announced the enhancement of its Mental Health and Neuroscience Real-World Data[…]